There is a solid foundation of evidence from longitudinal and interventional studies that a high intake of fruit is associated with a lower risk of hypertension and associated outcomes. However, the recommended target of five a day fruit is barely reached, even among health care providers, as recently shown in the UK, where only 17% of hospital staff succeeded. 1 Here, findings are in contrast to a plethora of scientific evidence, namely a positive association between the DASH score for fruit intake and hypertension in Vietnamese adults. The study was cross-sectional and included a relatively small sample of over 2400 adults when compared with other reports on fruit intake. The authors speculate that perhaps a high fructose intake may be accountable for the positive association with hypertension, but this may be unlikely when considering previous negative findings on fruit (and fruit juice) intake and the risk of hypertension development. Whether ethnic-specific sensitivity towards high fruit consumption and cardiovascular risk is at play also needs consideration.
What should be taken from this study and previous large-scale studies investigating individual fruits is that all fruits may not been created equal and there is potential to identify specific fruits that seem to be more cardioprotective than others, such as apples and pears. For example, the beneficial results for apples and raisins replicated earlier findings from the more than 28,000 participants from the Women's Health Study, 2 which also indicated oranges -but not bananas, strawberries or blueberries -to be associated with a reduced risk of hypertension.
Impact of early stages in life on cardiac development
The association of foetal and childhood growth patterns with cardiac volumes and left ventricular mass was assessed in 2827 children at 20 and 30 weeks of pregnancy, at birth and at 0.5, one, two, six and 10 years by cardiac magnetic resonance (CMR). Nearly half of the children (48%) were boys, 60% were Dutch and 4.5% were born preterm. Foetal and childhood growth were independently associated with childhood cardiac volumes and mass. More specifically, small size for gestational age at birth was associated with smaller cardiac ventricles relative to current body surface area, but with larger left ventricular mass-to-volume ratio (LMVR). On the contrary, children who were larger at birth and became taller and leaner in childhood were in the upper quartile of ventricular volumes and mass, but had lower LMVR. The study adds weight to existing data that both foetal and childhood growth are important for cardiovascular development. 3 The findings are also in line with previous studies which showed that preterm birth and low weight in infancy are related to increased cardiac mass in adult life. 4 In keeping with the accompanying editorial commentary, we may conclude by saying that the family plays an essential role in supporting the implementation of a healthy lifestyle for the mother and the child, and can actually shape our children's future hearts.
Cardiovascular risk in obese youth
An alarming presence of hypertension in apparently healthy schoolchildren has been recently reported. 5 Stricter criteria for the screening and diagnosis of hypertension in children were proposed by the 2017 American Academy of Pediatrics (AAP), namely <130/80 mmHg blood pressure (BP) values in adolescents aged 13 years or more, in contrast to 2016 European Society of Cardiology (ESC) and for European Society Hypertension (ESH) criteria, where a single cut off value of <140/90 mmHg was maintained. In the present issue, it is observed that in a sample of 2929 overweight/obese young people (6-16 years) defined non-hypertensive by ESH, 327 (11%) were categorized as hypertensive, based on the AAP criteria. These individuals presented several cardiovascular uncontrolled risk factors, namely a higher proportion of insulin resistance, high total cholesterol/ high-density lipoprotein cholesterol ratio and left ventricular hypertrophy, thus identifying a subgroup who may benefit from a more intensive preventive intervention.
The newest 2018 ESC/ESH Guidelines for the management of arterial hypertension clarify that long-term epidemiological studies have demonstrated a clear relationship between BP and longer-term risk of cardiovascular events and mortality in young adults with a BP >130/80 mmHg. 6 Furthermore, the Guidelines recommend earlier treatment to prevent more severe hypertension and the development of organ damage, which may not be completely reversible with later treatment. And, despite the absence of randomized controlled study evidence demonstrating the benefits of antihypertensive treatment in younger adults with uncomplicated grade 1 hypertension, Guidelines prescribe that treatment with BP-lowering drugs may be considered prudent. Anyway, healthy lifestyle advice should be prescribed, and its adoption carefully scrutinized, with the involvement of the family, and longer-term followup is essential as BP may rise. Finally, it is clarified that in younger patients with hypertension treated with BPlowering medication, office BP should be reduced to 130/80 mmHg if treatment is well tolerated.
Do cardiovascular disease prevention and rehabilitation programmes meet standards of quality?
Despite the persuasive evidence-base and the overwhelming cost-efficacy profile of cardiac rehabilitation and prevention programmes, the reality remains that it is only a minority of eligible patients that access and complete such programmes. For example, EUROASPIRE registries 7 demonstrate an actual fall in total participation from 43% to 34% in recent years. Thus, the expansion of prevention and rehabilitation services has to be campaigned for and realized. At the same time, it is essential that existing programmes operate at a level commensurate with the evidence-base and that all the core elements of these programmes are being delivered in accordance with agreed standards. In this direction the European Association of Preventive Cardiology (EAPC) of the ESC has taken up the challenge of developing a preventive cardiology centre accreditation system: 8 this system aims to test the performance and quality of preventive programmes around ESC related countries, against benchmarks set by a trusted party, 9 and receive recognition of the quality of infrastructure, equipment/ facilities, staff and care. In this issue the Perfect Cardiac Rehabilitation study is presented, an analysis of the structure, function and processes of rehabilitation and prevention programmes across Sweden, providing a valuable and unique insight into their alignment with ESC standards. Regarding some components, perceived as critical, such as hospital initiation, early commencement, core clinical staffing, minimum course duration and lifestyle risk factor interventions, the vast majority of Swedish cardiac rehabilitation services perform at a high level. In contrast, other important programme elements, such as medical risk factor management, the delivery of personalized education, multi-disciplinary team case review and the provision of written information concerning medical risk factors and individualized goals, were less well represented. This data further supports the EAPC's initiative on the accreditation system of preventive cardiology centres in Europe.
Exercise may also prevent bone fracture after myocardial infarction
Exercise training is highly recommended therapy in cardiovascular patients, including after a myocardial infarction (MI), as it improves survival and reduces hospitalization. Recent studies indicated the relation between cardiovascular diseases and risk of subsequent hip fractures. In particular, recent large cohort studies have demonstrated the association between the history of MI and osteoporotic fracture. Here, in an animal model involving 16-week-old male apolipoprotein E-deficient mice, eight weeks of exercise training improved bone mineral density, reduced bone resorption activity of osteoclast, accelerated bone formation activity and reduced Rho-kinase activity, associated with inflammatory response and osteoclast activity. These results should trigger studies to confirm these data outside the animal model used here (i.e. male apolipoprotein E-deficient mice).
Blood pressure classification and incident peripheral artery disease
Elevated BP plays a key role in the development of peripheral artery disease (PAD), which is an emerging potentially deadly condition. 10 Using data from a community-based middle-aged cohort at baseline (i.e. the Atherosclerosis Risk in Communities Study), demonstrated for the first time is the association of BP (in the context of the 2017 American College of Cardiology/American Heart Association BP classification), with incident PAD over a 25-year follow-up. During a median follow-up of 25.4 years, higher systolic BP categories showed significant associations with incident PAD in a graded fashion whereas, for diastolic BP, only >90 mmHg did. Interestingly, participants on anti-hypertensive medications had a greater risk of incident PAD than those who were not. It is likely that this was due to 'confounding by indication' whereby participants on anti-hypertensive medications had higher risk conditions than those not on anti-hypertensive medications (e.g. due to higher BP, longer duration of hypertension, and other comorbidities such as diabetes). Thus, this observation should not be interpreted as meaning that anti-hypertensive medications increase PAD risk.
In conclusion, we cannot agree more with the accompanying commentary where feeling the pulse of our patients is important either in the prediction of upcoming PAD or, more banally, to diagnose it, as a crucial part of our cardiovascular practice. Accordingly, BP management must be proactive, remembering that in most cases the lower the BP (especially systolic BP) the better, as long as this intensive anti-hypertensive therapy is well tolerated.
Socioeconomic position and education and one-year mortality in heart failure
Socioeconomic deprivation is associated with important risk factors, 11, 12 and consequently it is among the most important modifiers in cardiovascular risk score. Unfortunately, the gaps in life expectancy according to social status have increased in several European countries, including the wealthier ones, such as Denmark. 13 Here, based on the national Danish register, it is documented that among 145,690 patients with new-onset heart failure during the last 15 years, one-year mortality was inversely related to income: the differences between the lowest income quartile and the highest income quartile was 3.8% for women and 5.8% for men. Similar gradients in standardized mortality were present between the highest and lowest educational levels.
A better understanding of the causes underlying the association between socioeconomic indicators and mortality in patients with heart failure is a prerequisite to tailoring the proposed intervention based on the modifiable risk present. There is evidence that the association between lower socioeconomic status and mortality might be due to key differences in underlying latent factors including reduced health literacy, a greater burden of psychosocial risk factors, a higher prevalence of cardiovascular risk factors, such as of smoking/alcohol usage and obesity, and reduced access to care.
Exercise hypertension and myocardial fibrosis in athletes
Strenuous exercise may result in reversible changes of cardiac morphology and function with transient increase of serum markers of myocardial injury. 14 However, a portion of athletes reveal myocardial fibrosis on contrast-enhanced CMR, which represents a sign of irreversible myocardial injury. In a here presented study, 30 asymptomatic male triathletes masters (mean age 45 years) underwent CMR testing: the occurrence of myocardial oedema and cardiac dysfunction including left ventricular filling after an endurance race in individuals with and without myocardial fibrosis were evaluated. The authors found that CMR revealed late gadolinium enhancement (LGE) in 10 of 30 (33%) male triathletes, but in none of the male controls, as related to myocardial fibrosis. An interesting field of research will have to focus on gender differences between male and female athletes, the latter having revealed no LGE: in particular whether this finding will be the key explanation for a lower incidence of sudden cardiac death in female athletes will have to be elucidated. Moreover, the causality of structural adaptations found in athletes and elevated BP during exercise (chicken and egg) as well as the mechanistic underpinnings need to be determined
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